pharmaceuticals-and-healthcare

Global Biosimilar Insulin Market Research Report 2017


Published On : Mar 2017

Category : Insulin

No. of Pages : 113 pages

  • $2900
  • $5800

SPECIFY YOUR RESEARCH NEED

  • Query Type :
  •  
In this report, the global Biosimilar Insulin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Biosimilar Insulin in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India
Global Biosimilar Insulin market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Pfizer
Biogenomics
Eli Lilly
Gan&Lee Pharmaceuticals
Geropharm
Julphar Gulf Pharmaceutical Industries
Paras Biopharmaceuticals
Samsung Bioepis
Sedico
Wockhardt
Teva Pharmaceuticals
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Rapid Acting Insulins
Short Acting Insulins
Intermediate Insulins
Long Lasting Insulins
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Biosimilar Insulin for each application, including
Hospital
Clinic
Medical Center

Insulin, derived from the Latin word Insula meaning island is a type of peptide hormone secreted by the beta cells of the pancreatic islets. It is known for regulating the metabolism of protein, fats, and carbohydrates by endorsing the absorption of mainly glucose from the blood into skeletal muscle cells, liver, and fat. In these particular tissues the absorbed glucose is transformed into either fats or glycogen via glycogenesis or as in the case of liver, it transforms into both. Glucose creation and its evacuation into the blood by the liver is extensively inhibited by high insulin concentrations into the blood. Flowing insulin also impacts the amalgamation of proteins in a broad variety of tissues. Thus, it is an anabolic hormone, stimulating the transformation of small molecules in the blood into big molecules inside the cells. However, low insulin levels in blood has the adverse impact by stimulating widespread catabolism.

The report here talks about certain aspects of the Global biosimilar insulin market research report 2017 market which pronounces the future and present statistics of the market with respect to the trends in play. The main purpose of the of the study is to justify the occurrences in the Global biosimilar insulin market research report 2017 market by providing reader with useful and appropriate insights on the particulars of the market for the future scope of growth and available opportunities at the current state of the Global biosimilar insulin market research report 2017 market. The market research publication further deals with facets such as drivers, restraints, and prospects to gauge the outcome of the market during the forecast period mentioned in the report. The report also presents a brief yet exclusive outline of the particular market, which consists several accounts of the major aspects which are expected to trigger growth in the market or cause negative impact. The facets have been well examined and have also been handy in scrutinizing various other segments related to the market.

This report further digs deep into the Global biosimilar insulin market research report 2017 market by meticulously evaluating the production and industrial chain of the corresponding market. This will further help in procreating accurate data and statistics on multiple factors of the respective market such as information pertaining to policies of the government in the regional and global level, manufacture and circulation structure, production capacity, volume sold, and revenue earned among others. The indication that has been provided in the report has been extracted through the use of both primary and secondary methods. The research has been painstakingly conducted with cross checking of the facts and not leaving any loop holes.

The study furthermore provides an all-inclusive examination of the key regions stated in the report for the Global biosimilar insulin market research report 2017 market. For every region, the report pronounces the array of growth so far and clearing on what vendors can do to ensure achievement in the coming years. The research report will also be unfinished without a thorough assessment of the vendor landscape of the Global biosimilar insulin market research report 2017 market, which comprises the facts and figures, activities and inventions of the leaders in the Global biosimilar insulin market research report 2017 market.

List of Tables and Figures

Figure Picture of Biosimilar Insulin
Figure Global Biosimilar Insulin Production (K Pcs) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Biosimilar Insulin Production Market Share by Types (Product Category) in 2016
Figure Product Picture of Rapid Acting Insulins
Table Major Manufacturers of Rapid Acting Insulins
Figure Product Picture of Short Acting Insulins
Table Major Manufacturers of Short Acting Insulins
Figure Product Picture of Intermediate Insulins
Table Major Manufacturers of Intermediate Insulins
Figure Product Picture of Long Lasting Insulins
Table Major Manufacturers of Long Lasting Insulins
Figure Global Biosimilar Insulin Consumption (K Pcs) by Applications (2012-2022)
Figure Global Biosimilar Insulin Consumption Market Share by Applications in 2016
Figure Hospital Examples
Figure Clinic Examples
Figure Medical Center Examples
Figure Global Biosimilar Insulin Market Size (Million USD), Comparison (K Pcs) and CAGR (%) by Regions (2012-2022)
Figure North America Biosimilar Insulin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Biosimilar Insulin Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Biosimilar Insulin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Biosimilar Insulin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Biosimilar Insulin Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Biosimilar Insulin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Biosimilar Insulin Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Biosimilar Insulin Capacity, Production (K Pcs) Status and Outlook (2012-2022)
Figure Global Biosimilar Insulin Major Players Product Capacity (K Pcs) (2012-2017)
Table Global Biosimilar Insulin Capacity (K Pcs) of Key Manufacturers (2012-2017)
Table Global Biosimilar Insulin Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global Biosimilar Insulin Capacity (K Pcs) of Key Manufacturers in 2016
Figure Global Biosimilar Insulin Capacity (K Pcs) of Key Manufacturers in 2017
Figure Global Biosimilar Insulin Major Players Product Production (K Pcs) (2012-2017)
Table Global Biosimilar Insulin Production (K Pcs) of Key Manufacturers (2012-2017)
Table Global Biosimilar Insulin Production Share by Manufacturers (2012-2017)
Figure 2016 Biosimilar Insulin Production Share by Manufacturers
Figure 2017 Biosimilar Insulin Production Share by Manufacturers
Figure Global Biosimilar Insulin Major Players Product Revenue (Million USD) (2012-2017)
Table Global Biosimilar Insulin Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Biosimilar Insulin Revenue Share by Manufacturers (2012-2017)
Table 2016 Global Biosimilar Insulin Revenue Share by Manufacturers
Table 2017 Global Biosimilar Insulin Revenue Share by Manufacturers
Table Global Market Biosimilar Insulin Average Price (USD/Pcs) of Key Manufacturers (2012-2017)
Figure Global Market Biosimilar Insulin Average Price (USD/Pcs) of Key Manufacturers in 2016
Table Manufacturers Biosimilar Insulin Manufacturing Base Distribution and Sales Area
Table Manufacturers Biosimilar Insulin Product Category
Figure Biosimilar Insulin Market Share of Top 3 Manufacturers
Figure Biosimilar Insulin Market Share of Top 5 Manufacturers
Table Global Biosimilar Insulin Capacity (K Pcs) by Region (2012-2017)
Figure Global Biosimilar Insulin Capacity Market Share by Region (2012-2017)
Figure Global Biosimilar Insulin Capacity Market Share by Region (2012-2017)
Figure 2016 Global Biosimilar Insulin Capacity Market Share by Region
Table Global Biosimilar Insulin Production by Region (2012-2017)
Figure Global Biosimilar Insulin Production (K Pcs) by Region (2012-2017)
Figure Global Biosimilar Insulin Production Market Share by Region (2012-2017)
Figure 2016 Global Biosimilar Insulin Production Market Share by Region
Table Global Biosimilar Insulin Revenue (Million USD) by Region (2012-2017)
Table Global Biosimilar Insulin Revenue Market Share by Region (2012-2017)
Figure Global Biosimilar Insulin Revenue Market Share by Region (2012-2017)
Table 2016 Global Biosimilar Insulin Revenue Market Share by Region
Figure Global Biosimilar Insulin Capacity, Production (K Pcs) and Growth Rate (2012-2017)
Table Global Biosimilar Insulin Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table North America Biosimilar Insulin Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Europe Biosimilar Insulin Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table China Biosimilar Insulin Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Japan Biosimilar Insulin Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Southeast Asia Biosimilar Insulin Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table India Biosimilar Insulin Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Global Biosimilar Insulin Consumption (K Pcs) Market by Region (2012-2017)
Table Global Biosimilar Insulin Consumption Market Share by Region (2012-2017)
Figure Global Biosimilar Insulin Consumption Market Share by Region (2012-2017)
Figure 2016 Global Biosimilar Insulin Consumption (K Pcs) Market Share by Region
Table North America Biosimilar Insulin Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Europe Biosimilar Insulin Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table China Biosimilar Insulin Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Japan Biosimilar Insulin Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Southeast Asia Biosimilar Insulin Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table India Biosimilar Insulin Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Global Biosimilar Insulin Production (K Pcs) by Type (2012-2017)
Table Global Biosimilar Insulin Production Share by Type (2012-2017)
Figure Production Market Share of Biosimilar Insulin by Type (2012-2017)
Figure 2016 Production Market Share of Biosimilar Insulin by Type
Table Global Biosimilar Insulin Revenue (Million USD) by Type (2012-2017)
Table Global Biosimilar Insulin Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Biosimilar Insulin by Type (2012-2017)
Figure 2016 Revenue Market Share of Biosimilar Insulin by Type
Table Global Biosimilar Insulin Price (USD/Pcs) by Type (2012-2017)
Figure Global Biosimilar Insulin Production Growth by Type (2012-2017)
Table Global Biosimilar Insulin Consumption (K Pcs) by Application (2012-2017)
Table Global Biosimilar Insulin Consumption Market Share by Application (2012-2017)
Figure Global Biosimilar Insulin Consumption Market Share by Applications (2012-2017)
Figure Global Biosimilar Insulin Consumption Market Share by Application in 2016
Table Global Biosimilar Insulin Consumption Growth Rate by Application (2012-2017)
Figure Global Biosimilar Insulin Consumption Growth Rate by Application (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Biosimilar Insulin Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Biosimilar Insulin Production Growth Rate (2012-2017)
Figure Pfizer Biosimilar Insulin Production Market Share (2012-2017)
Figure Pfizer Biosimilar Insulin Revenue Market Share (2012-2017)
Table Biogenomics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biogenomics Biosimilar Insulin Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Biogenomics Biosimilar Insulin Production Growth Rate (2012-2017)
Figure Biogenomics Biosimilar Insulin Production Market Share (2012-2017)
Figure Biogenomics Biosimilar Insulin Revenue Market Share (2012-2017)
Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly Biosimilar Insulin Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Eli Lilly Biosimilar Insulin Production Growth Rate (2012-2017)
Figure Eli Lilly Biosimilar Insulin Production Market Share (2012-2017)
Figure Eli Lilly Biosimilar Insulin Revenue Market Share (2012-2017)
Table Gan&Lee Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Gan&Lee Pharmaceuticals Biosimilar Insulin Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Gan&Lee Pharmaceuticals Biosimilar Insulin Production Growth Rate (2012-2017)
Figure Gan&Lee Pharmaceuticals Biosimilar Insulin Production Market Share (2012-2017)
Figure Gan&Lee Pharmaceuticals Biosimilar Insulin Revenue Market Share (2012-2017)
Table Geropharm Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Geropharm Biosimilar Insulin Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Geropharm Biosimilar Insulin Production Growth Rate (2012-2017)
Figure Geropharm Biosimilar Insulin Production Market Share (2012-2017)
Figure Geropharm Biosimilar Insulin Revenue Market Share (2012-2017)
Table Julphar Gulf Pharmaceutical Industries Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Julphar Gulf Pharmaceutical Industries Biosimilar Insulin Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Julphar Gulf Pharmaceutical Industries Biosimilar Insulin Production Growth Rate (2012-2017)
Figure Julphar Gulf Pharmaceutical Industries Biosimilar Insulin Production Market Share (2012-2017)
Figure Julphar Gulf Pharmaceutical Industries Biosimilar Insulin Revenue Market Share (2012-2017)
Table Paras Biopharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Paras Biopharmaceuticals Biosimilar Insulin Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Paras Biopharmaceuticals Biosimilar Insulin Production Growth Rate (2012-2017)
Figure Paras Biopharmaceuticals Biosimilar Insulin Production Market Share (2012-2017)
Figure Paras Biopharmaceuticals Biosimilar Insulin Revenue Market Share (2012-2017)
Table Samsung Bioepis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Samsung Bioepis Biosimilar Insulin Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Samsung Bioepis Biosimilar Insulin Production Growth Rate (2012-2017)
Figure Samsung Bioepis Biosimilar Insulin Production Market Share (2012-2017)
Figure Samsung Bioepis Biosimilar Insulin Revenue Market Share (2012-2017)
Table Sedico Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sedico Biosimilar Insulin Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sedico Biosimilar Insulin Production Growth Rate (2012-2017)
Figure Sedico Biosimilar Insulin Production Market Share (2012-2017)
Figure Sedico Biosimilar Insulin Revenue Market Share (2012-2017)
Table Wockhardt Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Wockhardt Biosimilar Insulin Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Wockhardt Biosimilar Insulin Production Growth Rate (2012-2017)
Figure Wockhardt Biosimilar Insulin Production Market Share (2012-2017)
Figure Wockhardt Biosimilar Insulin Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biosimilar Insulin
Figure Manufacturing Process Analysis of Biosimilar Insulin
Figure Biosimilar Insulin Industrial Chain Analysis
Table Raw Materials Sources of Biosimilar Insulin Major Manufacturers in 2016
Table Major Buyers of Biosimilar Insulin
Table Distributors/Traders List
Figure Global Biosimilar Insulin Capacity, Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Global Biosimilar Insulin Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Biosimilar Insulin Price (Million USD) and Trend Forecast (2017-2022)
Table Global Biosimilar Insulin Production (K Pcs) Forecast by Region (2017-2022)
Figure Global Biosimilar Insulin Production Market Share Forecast by Region (2017-2022)
Table Global Biosimilar Insulin Consumption (K Pcs) Forecast by Region (2017-2022)
Figure Global Biosimilar Insulin Consumption Market Share Forecast by Region (2017-2022)
Figure North America Biosimilar Insulin Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure North America Biosimilar Insulin Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America Biosimilar Insulin Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure Europe Biosimilar Insulin Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Europe Biosimilar Insulin Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe Biosimilar Insulin Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure China Biosimilar Insulin Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure China Biosimilar Insulin Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China Biosimilar Insulin Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure Japan Biosimilar Insulin Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Japan Biosimilar Insulin Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan Biosimilar Insulin Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure Southeast Asia Biosimilar Insulin Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Biosimilar Insulin Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia Biosimilar Insulin Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure India Biosimilar Insulin Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure India Biosimilar Insulin Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India Biosimilar Insulin Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Table Global Biosimilar Insulin Production (K Pcs) Forecast by Type (2017-2022)
Figure Global Biosimilar Insulin Production (K Pcs) Forecast by Type (2017-2022)
Table Global Biosimilar Insulin Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Biosimilar Insulin Revenue Market Share Forecast by Type (2017-2022)
Table Global Biosimilar Insulin Price Forecast by Type (2017-2022)
Table Global Biosimilar Insulin Consumption (K Pcs) Forecast by Application (2017-2022)
Figure Global Biosimilar Insulin Consumption (K Pcs) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source

Send an Enquiry

  • * :
  • * :
  • :
  • :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top